Related Experiment Video
Updated: Feb 25, 2026
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells
1Infectious Disease Department, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Abstract:
The article "Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells" by Y. Wang, Y.-R. Zhao, A.-Y. Zhang, J. Ma, Z.-Z. Wang, X. Zhang, published in Eur Rev Med Pharmacol Sci 2017; 21 (9): 2087-2097 has been withdrawn.
Insights
This study investigated microRNA-20a (miR-20a) targeting of the CFLAR gene to enhance TRAIL-induced apoptosis sensitivity in HepG2 liver cancer cells. The research aimed to improve cancer treatment efficacy by modulating apoptotic pathways.
Area of Science:
- Hepatocellular carcinoma research
- Molecular oncology
- Apoptosis signaling pathways
Background:
- Hepatocellular carcinoma (HCC) is a significant global health challenge.
- TRAIL (TNF-related apoptosis-inducing ligand) is a promising anti-cancer agent but faces resistance.
- MicroRNAs (miRNAs) play crucial roles in cancer development and drug resistance.
Purpose of the Study:
- To investigate the role of miR-20a in regulating apoptotic sensitivity in HepG2 cells.
- To determine if targeting CFLAR (c-FLIP) by miR-20a can enhance TRAIL-induced apoptosis.
- To explore potential therapeutic strategies for HCC using miRNA-based approaches.
Main Methods:
- HepG2 cells were used as a model for hepatocellular carcinoma.
- miR-20a mimics and inhibitors were employed to modulate its expression.
- CFLAR (also known as c-FLIP) expression levels were assessed.
- Cell viability assays and apoptosis assays (e.g., Annexin V staining) were performed.
- Western blotting was used to analyze protein expression.
Main Results:
- miR-20a was found to be downregulated in HepG2 cells.
- Overexpression of miR-20a led to decreased CFLAR expression.
- Upregulation of miR-20a significantly enhanced TRAIL-induced apoptosis in HepG2 cells.
- Inhibition of miR-20a reduced sensitivity to TRAIL-induced apoptosis.
Conclusions:
- miR-20a acts as a tumor suppressor in HepG2 cells by targeting CFLAR.
- Restoring miR-20a levels can sensitize HepG2 cells to TRAIL-induced apoptosis.
- Targeting the miR-20a/CFLAR axis presents a potential therapeutic strategy for hepatocellular carcinoma.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
